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HERITABLE SKIN DISORDERS ^ NOVEL MUTATIONS
AND SPECTRUM OF PHENOTYPES
Genodermatoses comprise a group of phenotypically diverse con-
ditions with variable degrees of skin involvement. In some dis-
eases, there is only a minor, occasionally cosmetic, involvement
of the skin, hair, and/or nails, whereas in other conditions, skin
manifestations can be part of a severe multisystem disorder with
signi¢cant morbidity and even mortality. Over the past decade or
so, with the advent of molecular genetics in general, spectacular
progress has been made in understanding the genetic basis of
many heritable skin diseases, and in fact, mutations have now
been identi¢ed in about two hundred distinct genes in these dis-
eases (see Pulkkinen et al, 2002). Examination of the mutation
database in these diseases has revealed a number of both predict-
able and surprising genes. In several conditions, the mutated
genes could have been predicted on the basis of clinical, histo-
pathologic, immunohistochemical and/or ultrastructural analysis.
Such an example as epidermolysis bullosa, a group of blistering
diseases with fragility of skin at the dermal/epidermal basement
membrane zone. It was initially postulated that the structural
genes expressed at the dermal/epidermal junction could serve as
candidate genes, and this hypothesis has now been veri¢ed by de-
monstration of a large number of distinct mutations in as many as
10 di¡erent genes expressed within the cutaneous basement
membrane zone. At the same time, a number of mutated genes
have turned out to be rather surprising, and the exact relationship
of the mutations in the a¡ected genes and their consequences at
the clinical and morphological level are not well understood. An
example of such a condition is pseudoxanthoma elasticum, cha-
racterized by progressive calci¢cation of elastic ¢bers of the skin,
eyes, and the cardiovascular system. The mutated gene, ABCC6,
which encodes the MRP6 protein, a putative ATP-dependent
transmembrane transporter of unknown function, is expressed
primarily, if not exclusively, in the liver and in the kidneys, and
consequently, the pathomechanisms of this disease remain unex-
plained (see Uitto et al, 2002).
In this issue of the Journal, two articles deal with mutations
in single-gene Mendelian disorders, both of which are pheno-
typically pleiotropic but involve skin. First, Martinez-Mir et al
(2003) have examined families with multiple cutaneous and uter-
ine leiomyomas (MCUL), a disorder inherited in an autosomal
dominant pattern. There is considerable variability in the number
of tumors arising from the arrector pili muscle of hair follicles,
and the age of onset of the skin lesions is usually between the
second and fourth decade of life. Most females develop uterine
myomas, and in some families there is predisposition to renal cell
carcinoma. The disease causing gene was initially mapped to the
long arm of chromosome 1, region 1q42.3-q43, and mutations
were subsequently identi¢ed in the FH gene encoding fumarate
hydratase, a component of the tricarboxylic acid cycle involved in
energy production of the cells. Although the mechanism by
which FH mutations cause leiomyomas is currently unexplained,
it has been hypothesized that this enzyme acts as a selective tu-
mor suppressor gene. It is of interest to note that autosomal reces-
sive mutations in the same FH gene have been implicated in
complete de¢ciency of fumarate hydratase, which presents with
progressive encephalopathy and developmental delay. Interest-
ingly, some of the carrier parents of children with recessive FH
de¢ciency have been re-examined, and on occasion have been
found to show symptoms of MCUL which were undiagnosed
previously.
Martinez-Mir et al have now identi¢ed ¢ve families of varying
ethnic backgrounds with MCUL, and a total of 16 a¡ected indi-
viduals were available for their study. FH gene was examined by
PCR ampli¢cation of all exons and £anking intronic sequences,
followed by automated sequencing of the PCR products. This
approach was able to identify a unique mutation in the FH gene
in each of the ¢ve families, including a nonsense mutation, three
missense mutations, and a 4-bp frameshift deletion mutation.
Examination of the corresponding control populations did not
disclose their presence in una¡ected, unrelated individuals,
suggesting that they are not common polymorphisms, and are
therefore likely to be pathogenic. Careful examination of the
clinical presentation of the a¡ected individuals in this and a simi-
lar, previously published study failed to establish clear cut
genotype/phenotype correlations, as considerable phenotypic varia-
bility regarding skin and uterine involvement was noted. Neverthe-
less, identi¢cation of these family speci¢c mutations in the FH
gene now allows presymptomatic screening and careful early
monitoring of family members who are at risk for development
of the disease.
In another paper in this Journal, Whittock et al (2003) studied
X-linked dominant chondrodysplasia punctata (CDPX2; also
known as the Conradi^Hˇnermann^Happle syndrome) which is
characterized by a number of skeletal and neurologic abnormal-
ities associated with skin lesions. The skin abnormalities include
striate palmoplantar hyperkeratosis, follicular atrophoderma, and
pigmentary changes that follow the lines of Blaschko. These skin
lesions are often transient and may resolve even during early in-
fancy. The condition, being X-linked dominant, is usually lethal
in male embryos, although males in the context of a XXY kar-
yotype may survive. Complicating genetic counseling is the fact
that there is often a stepwise increase in disease severity from one
generation to the next (known as anticipation). The gene, EBP,
which harbors mutations in CDPX2, resides in the short arm of
X-chromosome, region Xp11.23-p11.22, and encodes emopamil
binding protein that functions as a D8-D7 sterol isomerase, a cri-
tical enzyme in the cholesterol biosynthetic pathway.
In this study, Whittock et al examined 11 unrelated patients
with CDPX2, all having hyperkeratosis and patchy ichthyotic
skin following the lines of Blaschko. There were also hair
abnormalities (sparse, ¢ne, and dry hair), cicatricial alopecia, and
nail dystrophy, in addition to developmental and neurologic
manifestations. The investigators were able to ¢nd mutations
in the EBP gene in all patients, 7 of which are novel. Since the
enzyme mutated in this condition is required for synthesis of
cholesterol, it appears that hemizygous males, dependent on
de novo cholesterol synthesis, either do not survive or survive with
severe neurologic defects. On the other hand, one of the clinical
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observations in this study is that the a¡ected heterozygous fe-
males have normal mental development, indicating that a su⁄-
cient amount of cholesterol is being synthesized from the
normal allele. The results of this study further con¢rm the diag-
nostic value of gas chromatography-mass spectrometry in
CDPX2 for determination of elevated cholesterol precursors in
serum. However, identi¢cation of mutations in the EBP gene
can now be used to con¢rm the diagnosis at the DNA level.
These ¢ndings also provide means for DNA-based prenatal diag-
nosis in pregnancies at risk for CDPX2.
GENETIC COMPLEXITYOF POLYGENIC DISORDERS ^
THE PARADIGM OF PSORIASIS
Following the great success in identifying distinct mutations
in the candidate genes in an increasing number of single-gene
Mendelian diseases, the emphasis is shifting towards analysis of
complex genetic disorders for identi¢cation of susceptibility
or protective genes. The paradigm of such conditions is psoriasis,
a common disorder with apparently multifactorial etiology. De-
monstrations of heritability in psoriasis date back to early 60s, in-
cluding studies on the prevalence, clinical course, and genetics of
psoriasis in isolated populations, such as in residents of the
Faroe Island, a group of islands halfway between Norway and
Iceland. Although estimates have suggested the overall heritabil-
ity of psoriasis may be as high as 90%, it is clear that various
environmental factors are needed for the expression of the
phenotype.
During the past decade, several genome-wide linkage studies
have been performed in attempts to identify putative susceptibil-
ity loci in psoriasis. There is now a consensus that a chromosomal
region on the short arm of chromosome 6, locus 6p21.3, which
contains the HLA-C major histocompatibility locus, is tightly
linked to psoriasis in di¡erent populations; this locus has been
designated as PSORS1. In addition to HLA-C, other genes
within PSORS1 have shown linkage, and in fact, recent evidence
has suggested that the HCR gene, encoding a putative transcrip-
tion factor expressed in the epidermis, is a candidate gene in psor-
iasis. Nevertheless, linkage studies suggest that the PSORS1 locus
accounts for less than 50% of the genetic component of psoriasis.
Accordingly, psoriasis has been linked to at least 6 additional sus-
ceptibility loci (PSORS2-7) with LOD scores 43. (LOD score,
logarithm of the odds, is a measure of the strength of the associa-
tion between a locus and the phenotype. Formally, a LOD score
43 establishes linkage and implies that the likelihood of an asso-
ciation by chance is less than 1 in 1000). The di⁄culty in ¢nding
additional minor susceptibility loci is that the strong in£uence of
PSORS1 can mask linkage to other loci.
In this issue, Asumalahti et al (2003) have examined a cohort of
psoriasis patients in families that did not show linkage to
PSORS1. Speci¢cally, the investigators examined 31 Finnish fa-
milies with at least three a¡ected individuals in each family, and
samples were collected from a total of 227 individuals among
whom 121 were a¡ected. A genome wide scan using microsatel-
lite markers placed upon the genome on the average at 9.1 cM
interval initially identi¢ed several potential loci on six chromo-
somes. However, further ¢ne-mapping with additional markers
revealed linkage to a locus on the short arm of chromosome 18,
18p11, in 9 families (LOD score 3.58). Bootstrap analysis revealed
that evidence for linkage between psoriasis and the locus on 18p
was primarily contributed by a single family (no. 3 inTable 1 of
the paper), although other families also supported the locus. As
expected, these families were negative for association with
PSORS1 locus, and conversely, analysis of the PSORS1 positive
families yielded negative scores across the 18p locus.
A previous study based on psoriasis sib pair analysis in the Brit-
ish population also yielded evidence for linkage to chromosome
18p. Thus, these two studies collectively establish a new suscept-
ibility locus. Of interest is the notion that the 18p locus also har-
bors a susceptibility locus for atopic disease, and psoriasis and
atopic disease also share other susceptibility regions on di¡erent
chromosomes. These observations suggest, perhaps, that genes at
these loci may have e¡ects on dermal in£ammation and immu-
nity contributing to the psoriasis phenotype. Unfortunately, no
con¢rmed genes have been located in the 18p susceptibility re-
gion as yet, and this study, which establishes another minor sus-
ceptibility locus in psoriasis, adds to the complexity of this
complex genodermatosis.
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Bootstrap method involves resampling of the original data by generat-
ing multiple replicate sets of data, which allows establishing the contribu-
tions of individual components of the database. In this paper, the original
dataset was repeatedly resampled for LOD score calculations by sequen-
tially excluding one of the families at a time (also known as ‘‘jack-knife
estimation’’). This strategy is called ‘‘bootstrap method’’ because to use the
data to generate more data seems analogous to a trick used by the ¢ctional
Baron Mˇnchhausen who, when he found himself at the bottom of a lake,
got out by pulling himself up by his bootstraps.
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